In the BioHarmony Drug Report Database

"Preview" Icon

Azelastine

Astelin, Astepro, Children’s Astepro, Optivar (azelastine) is a small molecule pharmaceutical. Azelastine was first approved as Astelin on 1996-11-01. It is used to treat allergic conjunctivitis, allergic rhinitis perennial, and vasomotor rhinitis in the USA. The pharmaceutical is active against histamine H1 receptor. Azelastine hydrochloride’s patents are valid until 2028-06-04 (FDA).

 

Trade Name

 

Astelin, Astepro, Children's Astepro, Optivar
 

Common Name

 

azelastine
 

ChEMBL ID

 

CHEMBL639
 

Indication

 

allergic conjunctivitis, allergic rhinitis perennial, vasomotor rhinitis
 

Drug Class

 

Antihistaminics (histamine-H1 receptor antagonists)

Image (chem structure or protein)

Azelastine structure rendering